Publication | Closed Access

Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents

Deguelin DerivativesNovel TherapyMedicineAnti-cancer AgentPharmacologyRadiation OncologyAnti-breast Cancer AgentsDrug Discovery